Ustunkaya Tuna, Quintana Joseph A, Kingeter Meredith, Hu Tiffany, Richardson Travis D, Stevenson William G, Lowenstern Angela M
Department of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Department of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
JACC Case Rep. 2025 Aug 6;30(22):104655. doi: 10.1016/j.jaccas.2025.104655.
To describe the feasibility and clinical considerations of a simultaneous transcatheter aortic valve replacement (TAVR) and ventricular tachycardia (VT) ablation in a critically ill patient with severe aortic stenosis and VT storm.
Preprocedural planning involved both electrophysiology and structural teams present. Transfemoral TAVR was performed using a Sapien S3 valve (Edwards Lifesciences) under general anesthesia with both transesophageal and transthoracic echocardiography guidance. While crossing the aortic valve into the left ventricle, VT occurred and was promptly cardioverted.We then transitioned to ablation of VTs, targeting their origin in the left ventricular scar. After the procedure, we monitored for recurrence of VT and potential device upgrade for heart block. Potential Pitfalls: Issues that can arise include hemodynamic instability during valve crossing and rapid pacing, risk of complete heart block, reinducibility of VT after valve implantation, and prolonged procedure time, which requires careful anesthetic and electrophysiologic planning.
TAKE-HOME MESSAGES: Combined TAVR and VT ablation is feasible and can effectively treat 2 life-threatening problems in high-risk patients. A team-based, individualized approach is essential for procedural success.
描述在一名患有严重主动脉瓣狭窄和室性心动过速(VT)风暴的危重病患者中同时进行经导管主动脉瓣置换术(TAVR)和室性心动过速消融的可行性及临床注意事项。
术前规划需要电生理团队和结构团队同时在场。在全身麻醉下,使用Sapien S3瓣膜(爱德华生命科学公司),在经食管和经胸超声心动图引导下经股动脉进行TAVR。在穿过主动脉瓣进入左心室时,发生了室性心动过速,并迅速进行了心脏复律。然后我们转而对室性心动过速进行消融,针对其起源于左心室瘢痕处。术后,我们监测室性心动过速的复发情况以及心脏传导阻滞潜在的器械升级情况。潜在陷阱:可能出现的问题包括瓣膜穿过和快速起搏期间的血流动力学不稳定、完全性心脏传导阻滞的风险、瓣膜植入后室性心动过速的可再诱导性以及手术时间延长,这需要仔细的麻醉和电生理规划。
TAVR和室性心动过速消融联合治疗是可行的,并且可以有效治疗高危患者的两种危及生命的问题。基于团队的个体化方法对于手术成功至关重要。